Principal Financial Group
AMRI

Principal Financial Group’s Albany Molecular Research Inc AMRI Stock Holding History

Principal Financial Group’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-171,060
Closed -$3.71M – 2285
2017
Q2 		$3.71M Buy
171,060
+374
+0.2% +$6.79K ﹤0.01% 1634
2017
Q1 		$2.4M Buy
170,686
+5,960
+4% +$97.6K ﹤0.01% 1706
2016
Q4 		$3.09M Buy
164,726
+2,418
+1% +$41.1K ﹤0.01% 1648
2016
Q3 		$2.68M Sell
162,308
-28,631
-15% -$424K ﹤0.01% 1633
2016
Q2 		$2.57M Buy
190,939
+6,155
+3% +$89.8K ﹤0.01% 1617
2016
Q1 		$2.83M Buy
184,784
+7,191
+4% +$113K ﹤0.01% 1549
2015
Q4 		$3.52M Buy
177,593
+8,052
+5% +$153K 0.01% 1502
2015
Q3 		$2.95M Buy
169,541
+22,271
+15% +$453K ﹤0.01% 1545
2015
Q2 		$2.98M Sell
147,270
-219
-0.1% -$4.23K ﹤0.01% 1588
2015
Q1 		$2.6M Buy
147,489
+3,306
+2% +$56.3K ﹤0.01% 1597
2014
Q4 		$2.35M Buy
144,183
+2,035
+1% +$37.3K ﹤0.01% 1650
2014
Q3 		$3.14M Buy
142,148
+25,901
+22% +$530K 0.01% 1537
2014
Q2 		$2.34M Buy
+116,247
New +$1.97M ﹤0.01% 1650
2013
Q4 		– Sell
-10,062
Closed -$130K – 2332
2013
Q3 		$130K Sell
10,062
-644
-6% -$7.92K ﹤0.01% 2196
2013
Q2 		$127K Buy
+10,706
New +$116K ﹤0.01% 2179

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Principal Financial Group's AMRI Position: Q3 2017 in Review

Principal Financial Group sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 171,060 shares — an estimated $3.71M sold.

Principal Financial Group first reported a position in AMRI in Q2 2013 and held it in 15 quarters. The position peaked at $3.71M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Principal Financial Group reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Principal Financial Group sold 171,060 Albany Molecular Research Inc shares in Q3 2017, an estimated $3.71M.
  • Principal Financial Group first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 15 quarters.
  • Principal Financial Group's Albany Molecular Research Inc position peaked at $3.71M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Principal Financial Group's 13F filing for Q3 2017, filed 2 Nov 2017.